VolitionRX Ltd (VNRX) has a current Price-to-Book (P/B) ratio of -0.86. Compared to its 3-year average P/B ratio of -8.42, the current P/B ratio is approximately -89.74% higher. Relative to its 5-year average P/B ratio of -1.32, the current P/B ratio is about -34.64% higher. VolitionRX Ltd (VNRX) has a Forward Free Cash Flow (FCF) yield of approximately -58.98%. Compared to its 3-year average FCF yield of -33.93%, the current FCF yield is approximately 73.86% lower. Relative to its 5-year average FCF yield of -24.79%, the current FCF yield is about 137.89% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for VNRX competitors is 1.88, providing a benchmark for relative valuation. VolitionRX Ltd Corp (VNRX.A) exhibits a P/S ratio of 9.25, which is 391.66% above the industry average. Given its robust revenue growth of 32.19%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of VNRX increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of VNRX in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is VNRX currently overvalued or undervalued?

What is VolitionRX Ltd (VNRX) fair value?

VNRX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of VolitionRX Ltd (VNRX) is between 0.17 to 0.27 according to relative valuation method.

How does VNRX's valuation metrics compare to the industry average?

The average P/S ratio for VNRX's competitors is 1.88, providing a benchmark for relative valuation. VolitionRX Ltd Corp (VNRX) exhibits a P/S ratio of 9.25, which is 391.66% above the industry average. Given its robust revenue growth of 32.19%, this premium appears sustainable.

What is the current P/B ratio for VolitionRX Ltd (VNRX) as of Mar 03 2026?

As of Mar 03 2026, VolitionRX Ltd (VNRX) has a P/B ratio of -0.86. This indicates that the market values VNRX at -0.86 times its book value.

What is the current FCF Yield for VolitionRX Ltd (VNRX) as of Mar 03 2026?

As of Mar 03 2026, VolitionRX Ltd (VNRX) has a FCF Yield of -58.98%. This means that for every dollar of VolitionRX Ltd's market capitalization, the company generates -58.98 cents in free cash flow.

What is the current Forward P/E ratio for VolitionRX Ltd (VNRX) as of Mar 03 2026?

As of Mar 03 2026, VolitionRX Ltd (VNRX) has a Forward P/E ratio of -1.66. This means the market is willing to pay $-1.66 for every dollar of VolitionRX Ltd's expected earnings over the next 12 months.

What is the current Forward P/S ratio for VolitionRX Ltd (VNRX) as of Mar 03 2026?

As of Mar 03 2026, VolitionRX Ltd (VNRX) has a Forward P/S ratio of 9.25. This means the market is valuing VNRX at $9.25 for every dollar of expected revenue over the next 12 months.

VNRX Valuation